Tango Therapeutics (NASDAQ:TNGX) focuses on discovering and delivering transformative cancer therapies. With a commitment to leveraging the latest in scientific research to address unmet needs in oncology, Tango is dedicated to identifying and exploiting cancer vulnerabilities through a precision medicine approach. Their projects revolve around developing a diverse pipeline of innovative treatment options that aim to improve outcomes for patients with various cancer types. Operating at the intersection of groundbreaking science and patient-centric development, Tango's objectives include advancing these projects through clinical trials, securing regulatory approvals, and ultimately making these therapies available to the patients who need them the most.